AzTrials
AzTrials

GingivitisSJW-CHX-RMENCT07882771

St. John's Wort Oil Versus Chlorhexidine Mouthwash for Gingival Problems After Rapid Maxillary Expansion

A study testing St. John's Wort Oil and Chlorhexidine in people with Gingivitis and Maxillary Transversal Deficiency, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial was to learn whether St. John's wort (Hypericum perforatum) oil helps gum healing in children and adolescents aged 11 to 16 years after treatment with a rapid maxillary expansion appliance. Read more about this study

Who is it for?
Ages 11 to 16 years
Conditions the study is for
Gingivitis, Maxillary Transversal Deficiency
What is being tested?
St. John's Wort Oil and Chlorhexidine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Jun 2019to 10 Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age between 11 and 16 years Maxillary transverse deficiency with bilateral posterior crossbite requiring rapid maxillary expansion No systemic disease Ability to read and understand the informed consent form Voluntary participation with written informed consent from the participant and parent/legal guardian

Who cannot join

  • Presence of systemic disease Severe facial deformity Not meeting the inclusion criteria

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Van Yuzuncu Yil University Faculty of Dentistry, Department of Orthodontics

    Van, Van, 65080

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effectiveness of Different Mouthwashes on Gingival Problems Following Rapid Maxillary Expansion

The goal of this clinical trial was to learn whether St. John's wort (Hypericum perforatum) oil helps gum healing in children and adolescents aged 11 to 16 years after treatment with a rapid maxillary expansion appliance. This appliance widens the upper jaw, but it covers a large part of the palate and makes cleaning difficult, which can cause gum redness, bleeding, swelling and pain after the appliance is removed.

The main questions it aimed to answer were:

Read more

Does St. John's wort oil improve gum health after the appliance is removed? Does it reduce pain in the days after appliance removal?

Researchers compared St. John's wort oil with chlorhexidine mouthwash, a commonly used oral antiseptic, and with a control group that used no antiseptic product.

Participants:

Were randomly assigned to one of three groups after removal of the expansion appliance Used St. John's wort oil as a mouthrinse or chlorhexidine three times a day for 7 days, or used no product (control group) Had their gums examined before the appliance was placed, when it was removed, and 7, 14 and 30 days later Recorded their pain level on a 0-10 scale on several days after appliance removal

Being tested
St. John's Wort Oil, Chlorhexidine
Keywords
Rapid maxillary expansion, Hypericum perforatum, St. John's wort oil, Chlorhexidine, Gingival inflammation, Orthodontic appliance
Medical subject headings
Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • St. John's Wort OilOther

    St. John's wort (Hypericum perforatum) oil was used as a mouthrinse three times daily for 7 days, starting after removal of the rapid maxillary expansion appliance. The product was dispensed in an identical, unlabeled bottle.

  • ChlorhexidineDrug

    Chlorhexidine gluconate mouthwash was used as a mouthrinse three times daily for 7 days, starting after removal of the rapid maxillary expansion appliance. The product was dispensed in an identical, unlabeled bottle.

Study groups in NCT07882771
Study groupRoleWhat they receive
St. John's Wort OilExperimentalParticipants rinsed with St. John's wort (Hypericum perforatum) oil three times daily for 7 days after removal of the rapid maxillary expansion appliance.
Receives: Other: St. John's Wort Oil
ChlorhexidineActive comparatorParticipants rinsed with chlorhexidine mouthwash three times daily for 7 days after removal of the rapid maxillary expansion appliance.
Receives: Drug: Chlorhexidine
ControlNo interventionParticipants received no mouthwash after removal of the rapid maxillary expansion appliance.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gingival Index (Löe & Silness)

    Gingival inflammation was assessed using the Löe and Silness gingival index (score 0-3; 0 = normal gingiva, 3 = severe inflammation with tendency to spontaneous bleeding). Higher scores indicate worse gingival health.

    Measured: Before appliance placement (baseline), at appliance removal, and 7, 14 and 30 days after appliance removal

Secondary outcomes (3)
  1. Plaque Index (Silness & Löe)

    Plaque accumulation was assessed using the Silness and Löe plaque index (score 0-3; 0 = no plaque, 3 = abundant plaque). Higher scores indicate more plaque accumulation.

    Measured: Before appliance placement (baseline), at appliance removal, and 7, 14 and 30 days after appliance removal

  2. Bleeding on Probing

    Percentage of sites showing bleeding within 15 seconds after gentle probing. Higher percentages indicate more gingival inflammation.

    Measured: Before appliance placement (baseline), at appliance removal, and 7, 14 and 30 days after appliance removal

  3. Pain Intensity (Visual Analogue Scale)

    Pain was self-reported by participants on a 10 cm visual analogue scale (0 = no pain, 10 = worst imaginable pain). Higher scores indicate more pain.

    Measured: Days 2, 4, 5 and 6 after appliance removal

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2026
  2. Study start10 Jun 2019
  3. Primary completion10 Nov 2020
  4. Study completion10 Nov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomly allocated to three parallel groups after removal of the rapid maxillary expansion appliance: St. John's wort oil mouthrinse, chlorhexidine spray, or no antiseptic agent (control).
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07882771
Sponsor's protocol ID
17.04.2019-08
Acronym
SJW-CHX-RME
Status last verified
Oct 2026
First submitted
13 Oct 2026
Last updated
20 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made publicly available because the participants were minors and the informed consent forms did not include permission for public data sharing. De-identified data are available from the corresponding author upon reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing St. John's Wort Oil and Chlorhexidine in people with Gingivitis and Maxillary Transversal Deficiency, run by Yuzuncu Yil University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gingival Index (Löe & Silness) (time frame: Before appliance placement (baseline), at appliance removal, and 7, 14 and 30 days after appliance removal). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in